3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinomagastroesophageal junction adenocarcinomaRecruitingPhase 32026-09-14NCT07043400
Lead Evaluation for Defibrillation and Reliability Post Approval StudyArrhythmias, Cardiac, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tachyarrhythmia, Tachycardia, cardiovascular disorder, heart disorderEnrolling by invitationNot stated2026-08-03NCT07005232
Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell MalignanciesMature B-Cell MalignanciesActive, not recruitingPhase 12026-06-22NCT04277637